Form 8-K - Current report:
SEC Accession No. 0001437749-22-009117
Filing Date
2022-04-18
Accepted
2022-04-18 16:25:05
Documents
16
Period of Report
2022-04-18
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dffn20220418_8k.htm   iXBRL 8-K 49773
2 EXHIBIT 3.1 ex_359622.htm EX-3.1 8166
3 EXHIBIT 99.1 ex_359623.htm EX-99.1 11875
8 image01.jpg GRAPHIC 5042
  Complete submission text file 0001437749-22-009117.txt   223779

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA dffn-20220418.xsd EX-101.SCH 3601
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dffn-20220418_def.xml EX-101.DEF 11916
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE dffn-20220418_lab.xml EX-101.LAB 15956
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dffn-20220418_pre.xml EX-101.PRE 12127
10 EXTRACTED XBRL INSTANCE DOCUMENT dffn20220418_8k_htm.xml XML 2672
Mailing Address 300 EAST MAIN STREET SUITE 201 CHARLOTTESVILLE VA 22902
Business Address 300 EAST MAIN STREET SUITE 201 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

EIN.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37942 | Film No.: 22832400
SIC: 2834 Pharmaceutical Preparations